×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5: Cardio-Metabolic - Regulatory and Scientific Updates
Session Chair(s)
Koki Nakamura, MD, PhD
Vice President, CVM Marketing, Japan Pharma Business Unit
Takeda Pharmaceutical Company Limited, Japan
Colette Strnadova, PhD
Senior Scientific Advisor, Therapeutic Products Directorate
Health Canada, Canada
Speaker(s)
The Cardiovascular Safety of Diabetes Drugs - The Alogliptin Experience
Emiko Koumura
Takeda Pharmaceutical Company Limited, Japan
Senior Director, Clinical Science, Japan Development Center
Japan’s Participation in a Global Cardiovascular Outcome Study
Masako Nakano, MD, PhD
Novartis Pharma K.K., Japan
Head, Translational Medicine Discovery & Profiling
The CSRC Diabetes CV Expert Perspective Paper - Overview and Recommendations
Mary Jane Geiger
ICON, United States
Vice President and TA Lead, Drug Development Services
Panel Discussion
All Session Speakers, United States
Have an account?